Hospira Reports Third-Quarter 20...(79.1 13.8 473.2 % Research a...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Hospira Reports Third-Quarter 2009 Results
Date:10/27/2009
79.1 13.8 473.2 % Research and development 160.8 158.9 1.2 % Acquired in-process research and development - 0.5 (100.0)% Selling, general and administrative 454.2 450.7 0.8 % -------- -------- Total operating cost and expenses 2,456.8 2,353.7 4.4 % -------- -------- Income From Operations 367.3 362.1 1.4 % Interest expense 80.2 87.2 (8.0)% Other expense (income), net 14.3 (6.5) (320.0)% -------- -------- Income Before Income Taxes 272.8 281.4 (3.1)% Income tax (benefit) expense (34.4) 65.1 (152.8)% -------- -------- Net Income $307.2 $216.3 42.0 % ======== ======== Earnings Per Common Share: Basic $1.92 $1.36 40.2 % ======== ======== Diluted $1.89 $1.34 41.3 % ======== ======== Weighted Average Common Shares Outstanding: Basic 160.4 159.1 1.3 % ======== ======== Diluted 162.3 161.4 0.6 % ======== ======== Adjusted Gross Profit (1)(2) $1,123.8 $1,050.1 7.0 % Adjusted Income From Operations (1) $533.8
'/>"/>
| SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
(Date:11/25/2009)...IN, China, Nov. 25 /PRNewswire-Asia-FirstCall/ -- ...l" or "the Company") (Nasdaq: CSKI ), a,leading f...and producing,over-the-counter drugs in the People... the Company recently passed the Chinese National ...ological Products ("ICPBP") examination,for two of...
(Date:11/25/2009)..., Mass., Nov. 25 According to Mill...on medical technology market intelligence, the nea...es will continue to see rapid growth over the next...MRG,s US Markets for Trauma Devices 2010 repor...c over the next five years, with competitors intro...
(Date:11/25/2009)... The Netherlands and JOHANNESBURG, November 25 /PR...sion and Pyxis Discovery announced today,that they...market both,companies, services. , Pyxis,...covery expertise,will be coupled with iThemba,s se...chemistry support to projects identified through P...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 1Pancreatic cancer risk decreased by one anti diabetic therapy increased by others 53409 2Dementia induced and blocked in Parkinsons fly model 53406 1Dementia induced and blocked in Parkinsons fly model 53406 2Dementia induced and blocked in Parkinsons fly model 53406 3House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 1House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 2House Tri Committee Bill Would Hurt Patients and Kill Jobs 53405 3[0] China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits[0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown[0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering
...UPERTINO, Calif., Aug. 12 DURECT Corporation,(Nas...Drug Administration,(FDA) has accepted the New Dru...ity Review. The FDA typically grants Priority Revi...emonstrate significant improvements,compared to ma...w of a drug,with Priority Review status is six mon...
...wing to Well-Established and Effective Insulin-Bas... 2017, According to a New Report from Decision ...ss., Aug. 12 Decision Resources, one of the,world...eutical and,healthcare issues, finds that the most...es market will be the shift in the standard of car...
Other Medicine Technology:REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market 2(Date:11/27/2009)...-SUR-SEINE, France, Nov. 27 Team G...cycling team dedicated to ethical sporting and dev...announced today that it will become Team Garmin-Tr... as a new sponsor of the team. Transitions Optical...yewear, offering the most advanced photochromic te...
(Date:11/27/2009)... XenaCare Holdings has announced that it has b...on, one of the largest nonprofit organizations ded...cation. , Delray Beach, F...Inc. (OTCBB: XCHO), a company specializing in the ...thcare products, has announced today that is has b...
(Date:11/27/2009)...g unprecedented medical, economic burdens, study p...ews) -- The number of people with diabetes in the ...25 years, a new study predicts. , That would br... with the disease, up from 23.7 million today. , ...ith diabetes will triple, the study also warns, ri...
(Date:11/27/2009)... Voyant Health™ announced today that Spe... its TraumaCad Enterprise orthopedic templating so... , (PRWEB) November 27, 2...pectrum Health (Grand Rapids, Michigan) has licens...solution and its TraumaCad Extend workflow solutio...
(Date:11/27/2009)... Specialist manufacturers who use medical load...illions of dollars by bringing in technology partn... numbers of pro-active medical manufacturers are c... stage of their projects, ensuring that progress w...s or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Diabetes Cases Expected to Double in 25 Years[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells
...ey, California have come out with a tremendous tec... information held in store in the human genome. Th...dowing". An analysis through this technique helps ... patterns' that identify these primate families un...
...t cancer are put off just with the news and then f...akes 6 weeks, disrupts their world completely. How...asier and less disruptive way of treating these ca...doctors will now be able to deliver the same cance...
...attempt to find out how various eating styles were...mpared the blood pressures of meat eaters, fish ea...ch were published in Public Health Nutrition, show...blood pressure and others with normal blood pressu...
...are one of the most exquisite pieces of engineerin...the eyes become vulnerable to a debilitating degen...eaking down, which ultimately might lead to blindn...ough nutrients that work as antioxidants.
The...
... sharp rise in the use of alternative treatments a...entifically document the effects of hundreds of he...now, there was// no easy access to current, compre...ill provide up-to-date information on the safety a...
...y of us, though very annoying, are just a harmless...for many sick people who have weakened immune syst...ttacks launched against their blood vessels and in...ering them ineffective for treatment of several se...
Other Medicine News:Health News:Primates reveal a new dimension to human genome, 2Health News:Cut meat to cut blood pressure 2Health News:New insights into herbal supplements 2Health News:Fight against Fungus - A new ray of hope 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |